GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINNW) » Definitions » Total Liabilities

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Total Liabilities : $3.29 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN Total Liabilities?

Inspira Technologies Oxy BHN's Total Liabilities for the quarter that ended in Jun. 2023 was $3.29 Mil.

Inspira Technologies Oxy BHN's quarterly Total Liabilities increased from Dec. 2022 ($2.54 Mil) to Mar. 2023 ($3.33 Mil) but then declined from Mar. 2023 ($3.33 Mil) to Jun. 2023 ($3.29 Mil).

Inspira Technologies Oxy BHN's annual Total Liabilities declined from Dec. 2021 ($5.52 Mil) to Dec. 2022 ($2.54 Mil) but then increased from Dec. 2022 ($2.54 Mil) to Dec. 2023 ($3.57 Mil).


Inspira Technologies Oxy BHN Total Liabilities Historical Data

The historical data trend for Inspira Technologies Oxy BHN's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspira Technologies Oxy BHN Total Liabilities Chart

Inspira Technologies Oxy BHN Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 5.02 2.69 5.52 2.54 3.57

Inspira Technologies Oxy BHN Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 2.54 3.33 3.29 3.57

Inspira Technologies Oxy BHN Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inspira Technologies Oxy BHN's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.984+(0.588+1.1102230246252E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=3.57

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=9.31-5.738
=3.57

Inspira Technologies Oxy BHN's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.268+(1.02+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=3.29

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=10.84-7.552
=3.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspira Technologies Oxy BHN Total Liabilities Related Terms

Thank you for viewing the detailed overview of Inspira Technologies Oxy BHN's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Traded in Other Exchanges
Address
2 Ha-Tidhar Street, Ra'anana, ISR, 4366504
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.